Pharmaceutical composition
US10888546B2 · kind B2 · utility
9Cited by
6References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2017 |
| Grant date | Jan 12, 2021 |
| Priority date | — |
| Expiry date | Sep 18, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one pharmaceutically acceptable salt of giycopyrrolate; and (ii) a propellant component comprising 1,1-difluoroethane (HFA-152a).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.